Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia.
Giglio F, Campodonico E, Lorentino F, Noviello M, Xue E, Greco R, Lazzari L, Bruno A, Lupo Stanghellini MT, Carrabba MG, La Starza R, Casucci M, Bonini C, Chiaretti S, Peccatori J, Foà R, Ciceri F. Giglio F, et al. Among authors: lazzari l. Front Oncol. 2023 Jan 10;12:1100105. doi: 10.3389/fonc.2022.1100105. eCollection 2022. Front Oncol. 2023. PMID: 36733349 Free PMC article.
Posttransplantation cyclophosphamide and sirolimus for prevention of GVHD after HLA-matched PBSC transplantation.
Greco R, Lorentino F, Morelli M, Giglio F, Mannina D, Assanelli A, Mastaglio S, Dalto S, Perini T, Lazzari L, Piemontese S, Corti C, Marcatti M, Bernardi M, Lupo Stanghellini MT, Ciceri F, Peccatori J. Greco R, et al. Among authors: lazzari l. Blood. 2016 Sep 15;128(11):1528-31. doi: 10.1182/blood-2016-06-723205. Epub 2016 Aug 5. Blood. 2016. PMID: 27495140 Free article. No abstract available.
Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide.
Greco R, Lorentino F, Nitti R, Lupo Stanghellini MT, Giglio F, Clerici D, Xue E, Lazzari L, Piemontese S, Mastaglio S, Assanelli A, Marktel S, Corti C, Bernardi M, Ciceri F, Peccatori J. Greco R, et al. Among authors: lazzari l. Front Immunol. 2019 Oct 1;10:2319. doi: 10.3389/fimmu.2019.02319. eCollection 2019. Front Immunol. 2019. PMID: 31632401 Free PMC article.
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant.
Greco R, Lorentino F, Albanese S, Lupo Stanghellini MT, Giglio F, Piemontese S, Clerici D, Lazzari L, Marcatti M, Mastaglio S, Xue E, Farina F, Pavesi F, Assanelli A, Carrabba MG, Marktel S, Vago L, Bonini C, Corti C, Bernardi M, Ciceri F, Peccatori J. Greco R, et al. Among authors: lazzari l. Transplant Cell Ther. 2021 Sep;27(9):776.e1-776.e13. doi: 10.1016/j.jtct.2021.05.023. Epub 2021 Jun 1. Transplant Cell Ther. 2021. PMID: 34087452 Free article.
COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.
Lupo-Stanghellini MT, Xue E, Mastaglio S, Oltolini C, Angelillo P, Messina C, Piemontese S, Girlanda S, Farina F, Lazzari L, Cicalese MP, Erbella F, Greco R, Locatelli M, Milani R, Peccatori J, Corti C, Marktel S, Assanelli A, Ciceri F. Lupo-Stanghellini MT, et al. Among authors: lazzari l. Bone Marrow Transplant. 2021 Sep;56(9):2312-2315. doi: 10.1038/s41409-021-01278-x. Epub 2021 Jun 30. Bone Marrow Transplant. 2021. PMID: 34193980 Free PMC article. No abstract available.
Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical Trial.
Lazzari L, Ruggeri A, Lupo Stanghellini MT, Mastaglio S, Messina C, Giglio F, Lorusso A, Perini T, Piemontese S, Marcatti M, Lorentino F, Xue E, Clerici D, Corti C, Bernardi M, Assanelli A, Greco R, Ciceri F, Peccatori J. Lazzari L, et al. Front Oncol. 2021 Sep 10;11:731478. doi: 10.3389/fonc.2021.731478. eCollection 2021. Front Oncol. 2021. PMID: 34568066 Free PMC article.
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type.
Lazzari L, Farina F, Lupo Stanghellini MT, Piemontese S, Marktel S, Mazzi B, Vago L, Milani R, Ferrario A, Bianchi B, Merli M, Ferreri AJM, Corti C, Peccatori J, Ruggeri A, Ciceri F. Lazzari L, et al. Curr Res Transl Med. 2021 Oct;69(4):103313. doi: 10.1016/j.retram.2021.103313. Epub 2021 Sep 28. Curr Res Transl Med. 2021. PMID: 34598023 No abstract available.
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation.
Lorentino F, Xue E, Mastaglio S, Giglio F, Clerici D, Farina F, Piemontese S, Bruno A, Lazzari L, Ruggeri A, Guggiari E, Lunghi F, Assanelli AA, Marktel S, Marcatti M, Carrabba MG, Bernardi M, Corti C, Peccatori J, Ciceri F, Greco R, Lupo-Stanghellini MT. Lorentino F, et al. Among authors: lazzari l. Blood Adv. 2022 May 24;6(10):3053-3057. doi: 10.1182/bloodadvances.2021006213. Blood Adv. 2022. PMID: 35078219 Free PMC article. No abstract available.
177 results